NCT05005793View on ClinicalTrials.gov

Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Metabolic AcidosisKidney Transplant; ComplicationsVascular Diseases
Interventions
DRUG

Sodium bicarbonate

Oral sodium bicarbonate at 0.5 mEq/kg-lean body weight/day

DRUG

Placebo

Placebo at 0.5 mEq/kg-lean body weight/day

Trial Locations (1)

80045

RECRUITING

University of Colorado, Aurora

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Colorado, Denver

OTHER

NCT05005793 - Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter